Company at a Glance
Price
Overview
Eisai Co., Ltd. is a global pharmaceutical company headquartered in Japan. Founded in 1941, the company focuses on developing, manufacturing, and marketing innovative medicines in several therapeutic areas, including neurology, oncology, and critical care.
Eisai is committed to improving the lives of patients and their families by addressing unmet medical needs and supporting the healthcare system. The company's product portfolio includes treatments for Alzheimer's disease, epilepsy, cancer, and other diseases.
With a presence in over 55 countries, Eisai has a global network of research and development, manufacturing, and marketing facilities. The company collaborates with partners around the world to expand its reach and bring its medicines to those in need.
In addition to its work in developing and commercializing medicines, Eisai also prioritizes corporate responsibility, sustainability, and diversity and inclusion initiatives. The company values the voice of patients and strives to put their interests at the center of everything it does.
Overall, Eisai is committed to making a positive impact on the global healthcare landscape and helping to enhance the quality of life for patients and their families.
How to explain to a 10 year old kid about the company?
π Want to read more about Eisai?
Sign up for free
or
log in
π Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting
RWlzYWkgaX MgYSBjb21w YW55IHRoYX QgZm9jdXNl cyBvbiBoZW FsdGhjYXJl IGFuZCBtZW RpY2luZS4g VGhleSBjcm VhdGUgZHJ1 Z3MgYW5kIH RyZWF0bWVu dHMgdG8gaG VscCBwZW9w bGUgZmVlbC BiZXR0ZXIg YW5kIHN0YX kgaGVhbHRo eS4gVGhpbm sgb2YgdGhl bSBsaWtlIG EgdGVhbSBv ZiBzY2llbn Rpc3RzIGFu ZCBkb2N0b3 JzIHdobyB3 b3JrIHRvZ2 V0aGVyIHRv IGZpbmQgd2 F5cyB0byBz b2x2ZSBoZW FsdGggcHJv YmxlbXMuPG JyPkVpc2Fp IG1ha2VzIG 1vbmV5IGJ5 IGRldmVsb3 BpbmcgdGhl c2UgbWVkaW NpbmVzIGFu ZCBzZWxsaW 5nIHRoZW0g dG8gaG9zcG l0YWxzLCBw aGFybWFjaW VzLCBhbmQg ZG9jdG9ycy 4gV2hlbiBz b21lb25lIG dldHMgc2lj ayBhbmQgbm VlZHMgbWVk aWNpbmUsIG RvY3RvcnMg bWlnaHQgcH Jlc2NyaWJl IEVpc2Fp4o CZcyBwcm9k dWN0cy4gVG hlIGNvbXBh bnkgYWxzby BnZXRzIG1v bmV5IGZyb2 0gb3RoZXIg cGxhY2VzLC BsaWtlIHJl c2VhcmNoIH BhcnRuZXJz aGlwcyBvci BzZWxsaW5n IHRoZWlyIG 1lZGljaW5l cyBpbiBkaW ZmZXJlbnQg Y291bnRyaW VzLjxicj5F aXNhaSBpcy BzdWNjZXNz ZnVsIGJlY2 F1c2UgdGhl eSBpbnZlc3 QgYSBsb3Qg b2YgdGltZS BhbmQgZWZm b3J0IGludG 8gcmVzZWFy Y2guIFRoZX kgYXJlIGFs d2F5cyBsb2 9raW5nIGZv ciBuZXcgd2 F5cyB0byBo ZWxwIHBlb3 BsZSwgZXNw ZWNpYWxseS BpbiBhcmVh cyBsaWtlIG NhbmNlciwg ZGVtZW50aW EsIGFuZCBv dGhlciBzZX Jpb3VzIGls bG5lc3Nlcy 4gQnkgZm9j dXNpbmcgb2 4gZmluZGlu ZyBpbXBvcn RhbnQgdHJl YXRtZW50cy wgRWlzYWkg YnVpbGRzIG EgZ29vZCBy ZXB1dGF0aW 9uIGFuZCB0 cnVzdCBmcm 9tIGRvY3Rv cnMgYW5kIH BhdGllbnRz Ljxicj5Jbi B0aGUgZnV0 dXJlLCBFaX NhaSBpcyBs aWtlbHkgdG 8gY29udGlu dWUgYmVpbm cgc3VjY2Vz c2Z1bCBiZW NhdXNlIHRo ZSB3b3JsZC BhbHdheXMg bmVlZHMgbm V3IG1lZGlj aW5lcyBhbm QgYmV0dGVy IGhlYWx0aG NhcmUgc29s dXRpb25zLi BBcyBtb3Jl IHBlb3BsZS BsaXZlIGxv bmdlciBsaX ZlcywgdGhl cmUgd2lsbC BiZSBhIGJp Z2dlciBuZW VkIGZvciBl ZmZlY3Rpdm UgdHJlYXRt ZW50cy4gRW lzYWkgaXMg YWxyZWFkeS B3b3JraW5n IG9uIGV4Y2 l0aW5nIG5l dyBpZGVhcy BhbmQgdGVj aG5vbG9naW VzIHRoYXQg Y2FuIG1ha2 UgbGlmZSBi ZXR0ZXIgZm 9yIHBlb3Bs ZSwgd2hpY2 ggaGVscHMg ZW5zdXJlIH RoZXnigJls bCBiZSBhcm 91bmQgZm9y IGEgbG9uZy B0aW1lLjxi cj4=
What is special about the company?
π Want to read more about Eisai?
Sign up for free
or
log in
π₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
MS4gRm91bm RlcidzIHBo aWxvc29waH k6IFRoZSBF aXNhaSBjb2 1wYW55IHdh cyBmb3VuZG VkIGJ5IGEg QnVkZGhpc3 QgbW9uaywg RHIuIFNoaW 5vYnUgRWlz YWksIGluID E5NDEuIEhl IGJlbGlldm VkIGluIHRo ZSBpbXBvcn RhbmNlIG9m ICJodW1hbi BoZWFsdGgg YXMgdGhlIG ZvdW5kYXRp b24gb2YgaG FwcGluZXNz IiBhbmQgdG hlIHJlc3Bv bnNpYmxlIH JvbGUgb2Yg YSBwaGFybW FjZXV0aWNh bCBjb21wYW 55IGluIHNv Y2lldHkuPG JyPjIuIEZv Y3VzIG9uIG h1bWFuIGhl YWx0aDogVG hlIGNvbXBh bnkncyBtaX NzaW9uIGlz IHRvICJnaX ZlIGZpcnN0 IHRob3VnaH RzIHRvIHBh dGllbnRzIG FuZCB0aGVp ciBmYW1pbG llcy4iIEl0 IHByaW9yaX RpemVzIHRo ZSBuZWVkcy BvZiBwYXRp ZW50cyBhbm QgYWltcyB0 byBwcm92aW RlIHNhZmUs IGVmZmVjdG l2ZSwgYW5k IGFmZm9yZG FibGUgbWVk aWNpbmVzLj xicj4zLiBH bG9iYWwgcH Jlc2VuY2U6 IEVpc2FpIG lzIGEgbXVs dGluYXRpb2 5hbCBjb21w YW55IHdpdG ggb3BlcmF0 aW9ucyBpbi A1NSBjb3Vu dHJpZXMgYW 5kIHJlZ2lv bnMgd29ybG R3aWRlLiBJ dCBoYXMgYS BzdHJvbmcg cHJlc2VuY2 UgaW4gSmFw YW4sIHRoZS BVUywgYW5k IEFzaWEsIG J1dCBhbHNv IGhhcyBhIG dyb3dpbmcg YnVzaW5lc3 MgaW4gRXVy b3BlIGFuZC BkZXZlbG9w aW5nIGNvdW 50cmllcy48 YnI+NC4gRG l2ZXJzZSBw cm9kdWN0IH BvcnRmb2xp bzogVGhlIG NvbXBhbnkn cyBwcm9kdW N0IHBvcnRm b2xpbyBpbm NsdWRlcyBh IGJyb2FkIH JhbmdlIG9m IHByZXNjcm lwdGlvbiBk cnVncywgb3 Zlci10aGUt Y291bnRlci BtZWRpY2F0 aW9ucywgYW 5kIG1lZGlj YWwgZGV2aW NlcyBpbiB2 YXJpb3VzIH RoZXJhcGV1 dGljIGFyZW FzIHN1Y2gg YXMgbmV1cm 9sb2d5LCBv bmNvbG9neS wgYW5kIGdh c3Ryb2ludG VzdGluYWwg ZGlzb3JkZX JzLjxicj41 LiBDb21taX RtZW50IHRv IHJlc2Vhcm NoIGFuZCBp bm5vdmF0aW 9uOiBFaXNh aSBpbnZlc3 RzIGEgc2ln bmlmaWNhbn QgcG9ydGlv biBvZiBpdH MgcmV2ZW51 ZXMgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 LCB3aXRoIG EgZm9jdXMg b24gaW5ub3 ZhdGl2ZSB0 cmVhdG1lbn RzIGZvciB1 bm1ldCBtZW RpY2FsIG5l ZWRzLiBJdC BhbHNvIGNv bGxhYm9yYX RlcyB3aXRo IGFjYWRlbW ljIGluc3Rp dHV0aW9ucy wgYmlvdGVj aCBjb21wYW 5pZXMsIGFu ZCBvdGhlci BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMgdG8gYW R2YW5jZSBu ZXcgdGhlcm FwaWVzLjxi cj42LiBQYX RpZW50IHN1 cHBvcnQgcH JvZ3JhbXM6 IFRoZSBjb2 1wYW55IG9m ZmVycyBzZX ZlcmFsIHBh dGllbnQgc3 VwcG9ydCBw cm9ncmFtcy wgc3VjaCBh cyBtZWRpY2 F0aW9uIGFz c2lzdGFuY2 UgYW5kIGVk dWNhdGlvbi Bwcm9ncmFt cywgdG8gaG VscCBwYXRp ZW50cyBhY2 Nlc3MgYW5k IHVuZGVyc3 RhbmQgdGhl aXIgbWVkaW NpbmVzLjxi cj43LiBTb2 NpYWwgYW5k IGVudmlyb2 5tZW50YWwg cmVzcG9uc2 liaWxpdHk6 IEVpc2FpIG lzIGNvbW1p dHRlZCB0by Bwcm9tb3Rp bmcgc3VzdG FpbmFibGUg cHJhY3RpY2 VzIGFuZCBl bnZpcm9ubW VudGFsIGNv bnNlcnZhdG lvbi4gSXQg YWxzbyBzdX Bwb3J0cyB2 YXJpb3VzIH NvY2lhbCBp bml0aWF0aX Zlcywgc3Vj aCBhcyBkaX Nhc3RlciBy ZWxpZWYgZW Zmb3J0cyBh bmQgaGVhbH RoY2FyZSBh Y2Nlc3MgaW 4gZGV2ZWxv cGluZyBjb3 VudHJpZXMu PGJyPjguIE F3YXJkcyBh bmQgcmVjb2 duaXRpb246 IFRoZSBjb2 1wYW55IGhh cyByZWNlaX ZlZCByZWNv Z25pdGlvbi Bmb3IgaXRz IGVmZm9ydH MgaW4gdmFy aW91cyBhcm VhcywgaW5j bHVkaW5nIH BhdGllbnQg YWR2b2NhY3 ksIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCwgYW 5kIGNvcnBv cmF0ZSBzb2 NpYWwgcmVz cG9uc2liaW xpdHkuIE1v c3Qgbm90YW JseSwgRWlz YWkgd2FzIG 5hbWVkIHRo ZSBtb3N0IG lubm92YXRp dmUgSmFwYW 5lc2UgcGhh cm1hY2V1dG ljYWwgY29t cGFueSBpbi AyMDIwIGJ5 IHRoZSBGb3 JiZXMgR2xv YmFsIDIwMD AgbGlzdC48 YnI+OS4gQ2 9ycG9yYXRl IGN1bHR1cm U6IFRoZSBj b21wYW55IH Byb21vdGVz IGEgc3VwcG 9ydGl2ZSBh bmQgY29sbG Fib3JhdGl2 ZSBjb3Jwb3 JhdGUgY3Vs dHVyZSwgZW 1waGFzaXpp bmcgZGl2ZX JzaXR5LCBp bmNsdXNpb2 4sIGFuZCB3 b3JrLWxpZm UgYmFsYW5j ZSBmb3IgaX RzIGVtcGxv eWVlcy48Yn I+MTAuIFN0 cm9uZyBmaW 5hbmNpYWwg cGVyZm9ybW FuY2U6IEVp c2FpIGhhcy BhIHN0cm9u ZyBmaW5hbm NpYWwgdHJh Y2sgcmVjb3 JkLCB3aXRo IHN0ZWFkeS ByZXZlbnVl IGdyb3d0aC BhbmQgcHJv Zml0YWJpbG l0eS4gVGhp cyBhbGxvd3 MgdGhlIGNv bXBhbnkgdG 8gY29udGlu dWUgaW52ZX N0aW5nIGlu IHJlc2Vhcm NoIGFuZCBk ZXZlbG9wbW VudCBhbmQg ZXhwYW5kaW 5nIGl0cyBn bG9iYWwgcH Jlc2VuY2Ug dG8gc2Vydm UgbW9yZSBw YXRpZW50cy 4=
What the company's business model?
π Want to read more about Eisai?
Sign up for free
or
log in
π Unlock our free guide: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
VGhlIEVpc2 FpIGNvbXBh bnkgaXMgYS BwaGFybWFj ZXV0aWNhbC Bjb21wYW55 IGZvY3VzZW Qgb24gZGlz Y292ZXJpbm csIGRldmVs b3BpbmcsIG FuZCBtYXJr ZXRpbmcgaW 5ub3ZhdGl2 ZSBwcm9kdW N0cyBmb3Ig dGhlIHRyZW F0bWVudCBv ZiB2YXJpb3 VzIGRpc2Vh c2VzLiBUaG VpciBidXNp bmVzcyBtb2 RlbCBpcyBj ZW50ZXJlZC Bhcm91bmQg dGhlaXIgcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IGVmZm9ydH MgdG8gY3Jl YXRlIG5ldy BkcnVncyBh bmQgdGhlcm FwaWVzLCBh cyB3ZWxsIG FzIGNvbW1l cmNpYWxpem luZyBhbmQg cHJvbW90aW 5nIHRoZWly IGV4aXN0aW 5nIHByb2R1 Y3RzIHRocm 91Z2ggcGFy dG5lcnNoaX BzIGFuZCBj b2xsYWJvcm F0aW9ucyB3 aXRoIG90aG VyIGNvbXBh bmllcy48Yn I+RWlzYWkn cyBidXNpbm VzcyBtb2Rl bCBhbHNvIG luY2x1ZGVz IGEgc3Ryb2 5nIGZvY3Vz IG9uIHBhdG llbnQgbmVl ZHMgYW5kIH Byb3ZpZGlu ZyBhY2Nlc3 MgdG8gdGhl aXIgcHJvZH VjdHMgaW4g dW5kZXJzZX J2ZWQgYXJl YXMuIFRoZX kgaGF2ZSBh IGdsb2JhbC BwcmVzZW5j ZSBhbmQgc3 RyaXZlIHRv IGV4cGFuZC B0aGVpciBy ZWFjaCB0by Bwcm92aWRl IGhlYWx0aG NhcmUgc29s dXRpb25zIH RvIHBlb3Bs ZSBhcm91bm QgdGhlIHdv cmxkLjxicj 5JbiBhZGRp dGlvbiB0by B0aGVpciBw aGFybWFjZX V0aWNhbCBi dXNpbmVzcy wgRWlzYWkg aGFzIGFsc2 8gZGl2ZXJz aWZpZWQgaW 50byBvdGhl ciBhcmVhcy BzdWNoIGFz IGRpYWdub3 N0aWNzLCBj b25zdW1lci BoZWFsdGhj YXJlIHByb2 R1Y3RzLCBh bmQgbWVkaW NhbCBkZXZp Y2VzLiBUaG V5IGFsc28g aW52ZXN0IG luIGRpZ2l0 YWwgaGVhbH RoIHRlY2hu b2xvZ2llcy BhbmQgaW5p dGlhdGl2ZX MgdG8gaW1w cm92ZSBwYX RpZW50IG91 dGNvbWVzIG FuZCBoZWFs dGhjYXJlIG RlbGl2ZXJ5 Ljxicj5Pdm VyYWxsLCBF aXNhaSdzIG J1c2luZXNz IG1vZGVsIG NvbWJpbmVz IGN1dHRpbm ctZWRnZSBy ZXNlYXJjaC BhbmQgZGV2 ZWxvcG1lbn Qgd2l0aCBz dHJhdGVnaW MgcGFydG5l cnNoaXBzLC BhIHBhdGll bnQtY2VudH JpYyBmb2N1 cywgYW5kIG RpdmVyc2lm aWNhdGlvbi B0byBlbnN1 cmUgYSBzdX N0YWluYWJs ZSBhbmQgc3 VjY2Vzc2Z1 bCBidXNpbm VzcyBpbiB0 aGUgcGhhcm 1hY2V1dGlj YWwgaW5kdX N0cnku
Is AI a threat?
AI presents several potential threats to companies in the pharmaceutical sector, including Eisai, through various mechanisms such as substitution, disintermediation, and margin pressure.
1. Substitution: AI and advancements in biotechnology can lead to the development of new treatments or diagnostic tools that may render existing products less relevant or obsolete. For example, if AI significantly enhances drug discovery processes or identifies more effective treatment pathways, Eisaiβs current offerings could be negatively affected if competitors leverage these technologies to bring more innovative products to market faster.
2. Disintermediation: AI can streamline processes, potentially reducing the need for traditional intermediaries in the healthcare ecosystem. This could impact Eisaiβs relationships with distributors, healthcare providers, or even patients. Direct-to-consumer models enabled by AI-driven diagnostics and treatment recommendations could bypass established distribution channels, reducing Eisaiβs control over how its products reach patients.
3. Margin Pressure: The integration of AI can lead to increased efficiency and lower costs in drug development and manufacturing processes. If competitors are able to use AI to lower their operating costs and improve outcomes, Eisai might face margin pressure as it needs to remain competitive on pricing or increase investment in its own AI capabilities. Furthermore, if AI-driven solutions become widely adopted in personalized medicine, Eisai may have to adapt its pricing strategies in response to new competition.
Overall, while AI presents opportunities for innovation and improvement, it also poses challenges that Eisai must address to maintain its competitive positioning in the market. Adapting to these changes will be crucial for mitigating potential threats.
Sensitivity to interest rates
The sensitivity of Eisaiβs earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Borrowing Costs: Eisai, like many companies, may have debt on its balance sheet. An increase in interest rates can raise borrowing costs, which would impact net income by increasing interest expenses. This may lead to lower earnings and cash flow if the company has significant debt.
2. Discount Rate on Cash Flows: Valuation models, particularly Discounted Cash Flow (DCF) analyses, use a discount rate that typically incorporates the risk-free rate (often influenced by interest rates). As interest rates rise, the discount rate would also increase, reducing the present value of future cash flows. This can negatively affect the companyβs valuation, making it appear less attractive to investors.
3. Investment Decisions: Higher interest rates can lead to reduced consumer spending and lower demand for pharmaceuticals, which may affect sales and ultimately earnings. Companies may also scale back on investments or R&D expenses in a higher interest rate environment, potentially impacting long-term growth prospects.
4. Equity Valuation: Interest rates can also impact overall market sentiment and valuation multiples. When rates rise, there may be a shift in investor preference from equities to fixed-income securities, leading to downward pressure on stock prices, including Eisaiβs shares.
5. Market Competition: Companies that rely heavily on external financing for expansion may struggle more with interest rate increases compared to those with strong cash reserves. This competitive disadvantage could affect market share and profitability.
Overall, Eisaiβs earnings, cash flow, and valuation are sensitive to changes in interest rates, and the extent of that sensitivity depends on their capital structure, market dynamics, and the broader economic environment.
Resilience to the future changes
π Want to read more about Eisai?
Sign up for free
or
log in
π Join us and grab your copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks"
QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgRW lzYWnigJlz IGVjb25vbW ljcyBvdmVy IHRoZSBuZX h0IDPigJM1 IHllYXJzIG lzIHRoZSBm YWlsdXJlIG 9mIGtleSBk cnVnIGNhbm RpZGF0ZXMg aW4gbGF0ZS 1zdGFnZSBj bGluaWNhbC B0cmlhbHMs IHBhcnRpY3 VsYXJseSBp ZiB0aGVzZS BhcmUgZm9y IHRyZWF0bW VudHMgdGhh dCBhcmUgY2 VudHJhbCB0 byB0aGVpci Bncm93dGgg c3RyYXRlZ3 kuIEZvciBp bnN0YW5jZS wgaWYgRWlz YWnigJlzIG xlYWQgQWx6 aGVpbWVy4o CZcyBkcnVn LCB3aGljaC BoYXMgZ2Vu ZXJhdGVkIH NpZ25pZmlj YW50IGV4cG VjdGF0aW9u cywgZmFjZX Mgc2V2ZXJl IGVmZmljYW N5IG9yIHNh ZmV0eSBpc3 N1ZXMgbGVh ZGluZyB0by BhIGNvbXBs ZXRlIGhhbH QgaW4gaXRz IGRldmVsb3 BtZW50IG9y IG1hcmtldC B3aXRoZHJh d2FsLCB0aG lzIGNvdWxk IGhhdmUgZG V2YXN0YXRp bmcgaW1wbG ljYXRpb25z Ljxicj5JZi BzdWNoIGEg c2NlbmFyaW 8gd2VyZSB0 byB1bmZvbG QsIHRoZSBj b21wYW554o CZcyBtYXJn aW5zIHdvdW xkIGxpa2Vs eSBuYXJyb3 cgc2lnbmlm aWNhbnRseS 4gVGhlIGNv c3RzIGFzc2 9jaWF0ZWQg d2l0aCBleH BlbnNpdmUg UiZhbXA7RC BpbnZlc3Rt ZW50cyB3b3 VsZCBub3Qg eWllbGQgcm V0dXJucywg bGVhZGluZy B0byByZWR1 Y2VkIHByb2 ZpdGFiaWxp dHkuIFRoZS Bsb3NzIG9m IGFudGljaX BhdGVkIHJl dmVudWUgZn JvbSB0aGUg ZmFpbGVkIH Byb2R1Y3Qg d291bGQgZn VydGhlciBj b21wb3VuZC B0aGlzIGlz c3VlLCBhcy Bwcm9qZWN0 ZWQgc2FsZX Mgd291bGQg dmFuaXNoLj xicj5JbiB0 ZXJtcyBvZi BjYXNoIGZs b3csIEVpc2 FpIGNvdWxk IGV4cGVyaW VuY2UgYSBz ZXZlcmUgY2 FzaCBjcnVu Y2guIFdpdG ggZGltaW5p c2hlZCByZX ZlbnVlcyBh bmQgb25nb2 luZyBmaXhl ZCBjb3N0cy wgaW5jbHVk aW5nIFImYW 1wO0QgZXhw ZW5zZXMsIH NhbGFyaWVz LCBhbmQgb3 BlcmF0aW9u YWwgY29zdH MsIGNhc2gg Zmxvd3MgY2 91bGQgdHVy biBuZWdhdG l2ZS4gVGhl IGNvbXBhbn kgbWlnaHQg YmUgZm9yY2 VkIHRvIGN1 dCBiYWNrIG 9uIFImYW1w O0Qgc3Blbm RpbmcgZm9y IG90aGVyIH Byb2plY3Rz LCB2ZW50dX JlIGludG8g Y29zdC1jdX R0aW5nIG1l YXN1cmVzLC BvciBzZWVr IGZpbmFuY2 luZyBvcHRp b25zIHRvIG 1haW50YWlu IGxpcXVpZG l0eS48YnI+ T24gdGhlIG JhbGFuY2Ug c2hlZXQgZn JvbnQsIHBy b2xvbmdlZC BuZWdhdGl2 ZSBjYXNoIG Zsb3cgd291 bGQgYWR2ZX JzZWx5IGFm ZmVjdCBFaX NhaeKAmXMg ZmluYW5jaW FsIGhlYWx0 aC4gVGhlIG NvbXBhbnkg bWlnaHQgc2 VlIGFuIGlu Y3JlYXNlIG luIGxldmVy YWdlIGlmIG l0IHRha2Vz IG9uIGRlYn QgdG8gY292 ZXIgbG9zc2 VzLCBsZWFk aW5nIHRvIG EgaGlnaGVy IGRlYnQtdG 8tZXF1aXR5 IHJhdGlvLi BBZGRpdGlv bmFsbHksIG ludmVzdG9y IGNvbmZpZG VuY2UgY291 bGQgd2FuZS wgY2F1c2lu ZyBhIGRlY2 xpbmUgaW4g c2hhcmUgcH JpY2UgYW5k IHBvc3NpYm x5IGFmZmVj dGluZyB0aG Ugb3ZlcmFs bCBtYXJrZX QgY2FwaXRh bGl6YXRpb2 4uIFRoaXMg c2NlbmFyaW 8gY291bGQg YWxzbyBsZW FkIHRvIHJl ZHVjZWQgaW 52ZXN0bWVu dCBpbiBncm 93dGggaW5p dGlhdGl2ZX MsIGZ1cnRo ZXIgaW1wYW N0aW5nIGZ1 dHVyZSBlYX JuaW5ncyBw b3RlbnRpYW wuPGJyPklu IHN1bW1hcn ksIHRoZSBm YWlsdXJlIG 9mIGNydWNp YWwgZHJ1Zy BjYW5kaWRh dGVzIGNvdW xkIHJlc3Vs dCBpbiBhIH NpZ25pZmlj YW50IGRvd2 50dXJuIGlu IEVpc2Fp4o CZcyBmaW5h bmNpYWwgbW V0cmljcywg aW5jbHVkaW 5nIGRlY3Jl YXNlZCBtYX JnaW5zLCBu ZWdhdGl2ZS BjYXNoIGZs b3csIGFuZC BhIHN0cmFp bmVkIGJhbG FuY2Ugc2hl ZXQgY2hhcm FjdGVyaXpl ZCBieSBpbm NyZWFzZWQg ZGVidCBhbm QgcmVkdWNl ZCBlcXVpdH kuPGJyPg==
Interesting facts about the company
π Want to read more about Eisai?
Sign up for free
or
log in
π Join us and grab your copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvZG 92MGNoNzJs U3piWXJwWW lPRWgud2Vi cCIgYWx0PS JFaXNhaSIg dGl0bGU9Ik Vpc2FpIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTUwIHdp ZHRoPTUwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE Vpc2FpPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TmCBDbGFp bSB5b3VyIG ZyZWUgZUJv b2s6IDxpPi JUaGUgQ2hl Y2tsaXN0IF ZhbHVlIElu dmVzdG9yIO KAlCBBIFNt YXJ0ZXIgV2 F5IHRvIFBp Y2sgU3RvY2 tzIjwvaT4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9wPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPCEtLQog ICAgICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdtYX JnaW4tdG9w OiAxMnB4Oy Bmb250LXNp emU6IDEzcH g7IGNvbG9y OiAjNDQ0Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IG5vdyBhbm QgZ2V0IG91 ciBmcmVlIG VCb29rIAog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGI+ VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr czwvYj4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IC0tPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID E2cHg7IGZv bnQtc2l6ZT ogMTRweDsg Y29sb3I6IC M0NDQ7IGZv bnQtZmFtaW x5OiAtYXBw bGUtc3lzdG VtLCBCbGlu a01hY1N5c3 RlbUZvbnQs IFNlZ29lIF VJLCBSb2Jv dG8sIEhlbH ZldGljYSBO ZXVlLCBzYW 5zLXNlcmlm OyBsaW5lLW hlaWdodDog MS42Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBIYX ZlIHlvdSBo ZWFyZCBhYm 91dCBvdXIg c2hvcnQgPH N0cm9uZyBz dHlsZT0nZm 9udC13ZWln aHQ6IDYwMD snPkRhaWx5 IFZpZGVvIE 5ld3NsZXR0 ZXI8L3N0cm 9uZz4/CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdodH RwczovL3d3 dy5pbnNpZ2 h0ZnVsdmFs dWUuY29tL2 5ld3NsZXR0 ZXIucGhwJy B0YXJnZXQ9 J19ibGFuay cgc3R5bGU9 J2NvbG9yOi AjMDA3QkZG OyB0ZXh0LW RlY29yYXRp b246IG5vbm U7IGZvbnQt d2VpZ2h0Oi A1MDA7IG1h cmdpbi1sZW Z0OiA2cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBGaW 5kIG91dCBt b3JlCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8L2E+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgCiAg ICAgICAgCi AgICAgICAg PHNwYW4gY2 xhc3M9J2Js dXJyZWQtdG V4dCc+CiAg ICAgICAgIC AgIE1TNGdU MjVsSUcgOW 1JRVZwYzJG cCA0b0NaY3 lCd2IzIEIx YkdGeUlIQn kgYjJSMVkz UnpJRyBsek lIUm9aU0J3 IGNtVnpZM0 pwY0ggUnBi MjRnZDJWcC BaMmgwSUd4 dmMzIE1nYl dWa2FXTmgg ZEdsdmJpd2 dRbSBWc2Rt bHh3cTRnIE tHeHZjbU5o YzIgVnlhVz RwTGlCSiBk Q0JwY3lCMG FHIFVnWm1s eWMzUWcgY0 hKbGMyTnlh WCBCMGFXOX VJSGRsIGFX ZG9kQ0JzYj MgTnpJR1J5 ZFdjZyBZWE J3Y205MlpX IFFnWW5rZ2 RHaGwgSUVa RVFTQnphVy A1alpTQXlN REUwIExqeG ljajR5TGkg QkZhWE5oYV NCcCBjeUIw YUdVZ1ptIG xtZEdnZ2JH RnkgWjJWem RDQndhRyBG eWJXRmpaWF YwIGFXTmhi Q0JqYjIgMX dZVzU1SUds dSBJRXBoY0 dGdUlHIEZ1 WkNCb1lYTW cgWVNCemRI SnZibSBjZ2 NISmxjMlZ1 IFkyVWdhVz RnZEcgaGxJ R2RzYjJKaC BiQ0J3YUdG eWJXIEZqWl hWMGFXTmgg YkNCdFlYSn JaWCBRdVBH SnlQak11IE lGUm9aU0Jq YjIgMXdZVz U1SUhkaCBj eUJtYjNWdV pHIFZrSUds dUlERTUgTk RFZ1lua2dW RyA5NWIycH BJRTVoIGFY UnZMQ0IzYU cgOGdkMkZ6 SUdFZyBibU YyWVd3Z1pH IDlqZEc5eU lHSmwgWm05 eVpTQnpkRy BGeWRHbHVa eUJvIGFYTW diM2R1SUgg Qm9ZWEp0WV dObCBkWFJw WTJGc0lHIE oxYzJsdVpY TnogTGp4aW NqNDBMaSBC VWFHVWdibU Z0IFpTQkZh WE5oYVMgQm piMjFsY3lC bSBjbTl0SU hSb1pTIEJ6 ZFhKdVlXMW wgSUc5bUlH RWdabSBGdG IzVnpJRXBo IGNHRnVaWE 5sSUcgMXZi bXNnWVc1ay BJSEJvYVd4 dmMyIDl3YU dWeUxDQkYg YVhOaGFTQm FaVyA1cWFT d2dkMmh2IE lHbHpJR055 WlcgUnBkR1 ZrSUhkcCBk R2dnYVc1MG NtIDlrZFdO cGJtY2cgV2 1WdUlFSjFa RyBSb2FYTn RJSFJ2IElF cGhjR0Z1TG ogeGljajQx TGlCVSBhR1 VnWTI5dGNH IEZ1ZWVLQW 1YTWcgY21W elpXRnlZMi BnZ2FYTWda bTlqIGRYTm xaQ0J2Ymkg Qm1iM1Z5SU cxaCBhVzRn WVhKbFlYIE 02SUc1bGRY SnYgYkc5bm VTd2diMiA1 amIyeHZaM2 tzIElHZGhj M1J5YjIgbH VkR1Z6ZEds dSBZV3dnWk dsemIzIEpr WlhKekxDQm ggYm1RZ2FX NTBaVyBkeV lYUnBkbVVn IGJXVmthV0 5wYm0gVXVQ R0p5UGpZdS BJRVZwYzJG cElHIGhoY3 lCaElHMXAg YzNOcGIyNG dkRyA4Z1oy bDJaU0JtIG FYSnpkQ0Iw YUcgOTFaMm gwSUhSdiBJ SEJoZEdsbG JuIFJ6SUdG dVpDQjAgYU dWcGNpQm1Z VyAxcGJHbG xjeXdnIFlX NWtJSFJ2SU cgbHVZM0ps WVhOcCBibW NnZEdobElH IEpsYm1WbW FYUnogSUhS b1lYUWdhRy BWaGJIUm9J R05oIGNtVW djSEp2ZG0g bGtaWE11UE dKeSBQamN1 SUVsdUlHIE ZrWkdsMGFX OXUgSUhSdk lIQnlaWCBO amNtbHdkR2 x2IGJpQnRa V1JwWTIgRj BhVzl1Y3l3 ZyBSV2x6WV drZ1lXIHh6 YnlCd2NtOW sgZFdObGN5 QnZkbSBWeU xYUm9aUzFq IGIzVnVkR1 Z5SUcgUnlk V2R6TENCay BhV0ZuYm05 emRHIGxqY3 l3Z1lXNWsg SUdOc2FXNX BZMiBGc0lH NTFkSEpoIF kyVjFkR2xq WVcgeHpMan hpY2o0NCBM aUJGYVhOaG FTIEJwY3lC amIyMXQgYV hSMFpXUWdk RyA4Z2MzVn pkR0ZwIGJt RmlhV3hwZE gga2dZVzVr SUhOdiBZMm xoYkNCeVpY IE53YjI1em FXSnAgYkds MGVTd2dZVy A1a0lHaGhj eUJpIFpXVn VJSEpsWTIg OW5ibWw2Wl dRZyBabTl5 SUdsMGN5IE JsWm1admNu UnogSUdsdU lHVnVkbSBs eWIyNXRaVz UwIFlXd2dZ Mjl1YzIgVn lkbUYwYVc5 dSBMQ0JsZE docFkyIEZz SUdKMWMybH UgWlhOeklI QnlZVyBOMG FXTmxjeXdn IFlXNWtJR0 52Y24gQnZj bUYwWlNCai BhWFJwZW1W dWMyIGhwY0 M0OFluSSsg T1M0Z1ZHaG xJRyBOdmJY Qmhibm5pIG dKbHpJR3h2 WjIgOHNJR0 VnY0dGcCBj aUJ2WmlCam IyIHh2Y21a MWJDQm8gWV c1a2N5Qnla VyBGamFHbH VaeUJ2IGRY UWdkRzhnWm 0gOXliU0Jo SUdobCBZWE owTENCeVpY IEJ5WlhObG JuUnogSUVW cGMyRnA0by BDWmN5Qmta V1JwIFkyRj BhVzl1SUgg UnZJR2x0Y0 hKdiBkbWx1 WnlCc2FYIF psY3lCaGJt UWcgWTNKbF lYUnBibSBj Z2FHRnliVz l1IGVTQnBi aUIwYUcgVW dkMjl5YkdR dSBQR0p5UG pFd0xpIEJK YmlBeU1ESX cgTENCRmFY TmhhUyBCaG JtNXZkVzVq IFpXUWdZU0 J3WVggSjBi bVZ5YzJocC BjQ0IzYVhS b0lIIFJvWl NCQ2FXeHMg SUNZZ1RXVn NhVyA1a1lT QkhZWFJsIG N5QkdiM1Z1 WkcgRjBhVz l1SUhSdiBJ R1JsZG1Wc2 IzIEFnWVNC emFXNW4gYk dVdFpHOXpa UyBCamRYSm xJR1p2IGNp QnRZV3hoY2 0gbGhMQ0Iz YUdsaiBhQ0 JoWm1abFkz IFJ6SUcxcG JHeHAgYjI1 eklHOW1JSC BCbGIzQnNa U0JsIFlXTm 9JSGxsWVgg SWdhVzRnWk dWMiBaV3h2 Y0dsdVp5IE JqYjNWdWRI SnAgWlhNdQ ogICAgICAg IDwvc3Bhbj 4KICAgICAg ICAKICAgIC AgICA=
See Company Q&A
π Get full analytics about Eisai
Sign up for free
or
log in
π₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"